Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Nov 2025, Dec 2025, Jan 2026 and Feb 2026.
- Largest single sale: $7.4M (14,625 shares) of United Therapeutics Corp on Dec 29, 2025. Filing
- Last sale before this period: Oct 13, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| United Therapeutics Corp (UTHR) | President and COO | Jun 27, 2016 | May 14, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Mar 15, 2026, United Therapeutics Corp: 33,382 shares vested; 14,706 shares withheld by the company for taxes (some held indirectly). 1 filing: 1
- Feb 23, 2026, United Therapeutics Corp: sold 14,440 shares for $6.8M, under a disclosed plan; 28,880 shares converted (some held indirectly). 1 filing: 1
- Feb 17, 2026, United Therapeutics Corp: sold 22,500 shares for $10.8M, under a disclosed plan; 45,000 shares converted (some held indirectly). 1 filing: 1
- Feb 9, 2026, United Therapeutics Corp: sold 22,500 shares for $10.7M, under a disclosed plan; 45,000 shares converted (some held indirectly). 1 filing: 1
- Feb 2, 2026, United Therapeutics Corp: sold 22,500 shares for $10.6M, under a disclosed plan; 22,500 shares acquired by exercising options (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.